Romiplostim N01 in the Treatment of Thrombocytopenia Caused by Cytotoxic Drugs in Breast Cancer Patients
Clinical trial NCT07162519 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07162519
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-20
- Primary completion
- 2026-08-30
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.